Bayer-Monsanto Denies Role in Théo’s Illness
Table of Contents
- French Family Takes Bayer to Court Over Alleged Glyphosate-Related Birth Defects
- French Family vs. Bayer: Glyphosate and Birth Defects – A Q&A
- Frequently Asked Questions
- Q: What is the core of the Grataloup family’s lawsuit against Bayer?
- Q: Who are the key individuals involved in this case?
- Q: What evidence is the Grataloup family presenting in court?
- Q: What is Bayer’s defense in this case?
- Q: What specific health challenges is Théo Grataloup facing?
- Q: What has been the impact of Théo’s health condition on his family?
- Q: What is the meaning of the “Monsanto Papers”?
- Q: What is the legal status of glyphosate in the European union?
- Q: Is this the first time Monsanto/Bayer has faced legal action over the effects of glyphosate?
- Q: what are the next steps in the Grataloup case?
- Q: How does this case mirror david and Goliath’s famous battle?
- Table: Summary of key arguments
- Frequently Asked Questions
VIENNA, France (Isère) — After a seven-year legal battle, teh Grataloup family has brought a case against the French subsidiary of Bayer, which acquired Monsanto in 2018, alleging that their son’s birth defects were a result of prenatal exposure to glyphosate, the active ingredient in Monsanto’s Roundup herbicide.
Sabine and Thomas Grataloup are seeking to hold the agrochemical giant accountable for severe malformations affecting their son Théo’s esophagus, larynx, and respiratory system. Théo is now 17 years old. The courtroom in Vienna, a town south of Lyon, was filled with supporters and journalists for the hearing, marking a significant moment in a legal saga that began nearly two decades ago.
In August 2006, Sabine Grataloup, unaware that she was in the early weeks of pregnancy, used a glyphosate-based weed killer marketed under the brand name Glyper on her property. Already a mother to a two-year-old daughter,she had “no reason to be wary,” according to court documents,as Monsanto had promoted its products as safe for both the environment and human health. Lawyers for the Grataloup family emphasized that the critical period for the development of the affected organs coincided with this early stage of pregnancy.
“A daily routine dictated by constant care and surgical interventions.”
Alice Gourlay-Duplessis,the family’s attorney,detailed the profound impact of Théo’s health condition on the entire family,describing it as ”a daily routine dictated by constant care and surgical interventions.” Théo underwent his first surgery within 24 hours of birth and has since endured more than 50 operations under general anesthesia.
Until the age of three, Théo communicated through gestures and relied on a feeding tube until he was six. He currently has a tracheostomy, a surgical opening in his neck, to aid his breathing and speech, which gives his voice a metallic quality. Gourlay-Duplessis presented scientific studies indicating the teratogenic effects—the ability to cause malformations in embryos—of glyphosate. She also noted that the International Center for Research against Cancer classified glyphosate as a probable carcinogen in 2004.
Gourlay-Duplessis argued that “serious, precise, and concordant presumptions demonstrate the causal link” between glyphosate exposure and Théo’s disabilities. She cited the “very telling chronology” of events, “the absence of other factors” that could explain the malformations, and their “remarkable character” as confirmed by medical experts.
Bertrand Repolt, another attorney for the family, asserted that Monsanto was not only aware of the toxicity of its herbicide but also actively concealed it.He referred to the ”Monsanto Papers,” internal documents from the U.S. multinational revealed in 2017, which allegedly exposed an organized disinformation campaign aimed at ensuring the continued marketing of the product.
Bayer’s Defence
Bayer’s legal team challenged the grataloup family’s claims. Jean-daniel Bretzner, Bayer’s lawyer, argued for the dismissal of the case, contending that Bayer France was neither the producer nor the distributor of the herbicide, pointing to other legal entities within the Bayer group.
Bretzner also raised the issue of foreclosure, arguing that the statute of limitations for filing the lawsuit had expired. he questioned the credibility of witnesses who claimed to have seen Sabine grataloup using glyphosate in August 2006, suggesting their memories were unreliable. He also disputed the authenticity of a photograph of the weed killer presented as evidence, claiming the label indicated it could not have been purchased in 2005, as the mother stated. Furthermore, he dismissed the significance of a decision by a compensation fund for pesticide victims in 2022, which recognized a link between Théo’s malformations and glyphosate.
Citing the European Union’s reauthorization of glyphosate for ten years in 2023,Bretzner concluded that there was “no causal link” between glyphosate and the adolescent’s disabilities,nor “any effect on human reproduction,” a statement met with disbelief from the audience.
“Composure” and “sense of show”
“This hearing highlighted how much we are David against Goliath,” Sabine Grataloup said after the court session. “In the opposing party’s argument, it was a bit like, ‘It’s not me, it’s my Belgian cousin.’ And we, a small family in Nord-Isère, would have to sue the Belgian company, then the Italian company, and probably also the American company…”
Théo, dressed in a navy blue suit and white shirt, noted the “composure” and “sense of show” displayed by the opposing side. He praised the compelling arguments of his lawyers and expressed “full confidence” in the French justice system.
In France, Monsanto was previously convicted in 2012 for the poisoning of farmer paul François by Lasso, another herbicide produced by the company. A decision in the Grataloup case is expected on July 31.
French Family vs. Bayer: Glyphosate and Birth Defects – A Q&A
This article delves into the ongoing legal battle between the Grataloup family and bayer, focusing on the alleged link between glyphosate exposure and the birth defects experienced by their son, Théo. We break down the key questions, arguments, and implications of this complex case.
Frequently Asked Questions
Q: What is the core of the Grataloup family’s lawsuit against Bayer?
A: The Grataloup family alleges that their son, Théo, was born with severe malformations affecting his esophagus, larynx, and respiratory system due to prenatal exposure to glyphosate, the active ingredient in Monsanto’s roundup herbicide. The Grataloups are holding bayer,which acquired Monsanto in 2018,accountable for these alleged birth defects,and therefore,seeking compensation.
Q: Who are the key individuals involved in this case?
A: Key figures include:
- Sabine and Thomas Grataloup: The parents of Théo, leading the legal fight.
- Théo Grataloup: The 17-year-old son who has suffered from meaningful birth defects.
- Alice Gourlay-Duplessis and Bertrand Repolt: The lawyers representing the Grataloup family.
- Jean-Daniel Bretzner: Bayer’s lawyer,defending the company.
Q: What evidence is the Grataloup family presenting in court?
A: The family’s lawyers are presenting several pieces of evidence:
- Chronology of Events: Emphasis on the timing of glyphosate exposure in early pregnancy coinciding with critical organ growth.
- Medical Expert Testimony: Experts who have confirmed the remarkable character of the malformations.
- Scientific Studies: Research indicating the potential teratogenic effects (ability to cause malformations) of glyphosate. The impact is specifically on the development of Théo’s esophagus, larynx, and respiratory system.
- “Monsanto Papers”: Internal documents from the U.S. multinational company (Monsanto) allegedly detailing an organized disinformation campaign to ensure continued product marketing.
Q: What is Bayer’s defense in this case?
A: Bayer’s legal team has countered by:
- Challenging liability: Arguing that Bayer France was neither the producer nor the distributor of the herbicide in question, shifting responsibility to other entities within the bayer group.
- Raising Statute of Limitations: Contending that the lawsuit may have been filed beyond the legal time limits.
- Questioning Evidence: Casting doubt on the credibility of witnesses and the authenticity of evidence, such as a photograph of the product label.
- Denying Causation: Asserting that there is no proven causal link between glyphosate exposure and Théo’s disabilities, citing the EU’s reauthorization of glyphosate for ten years in 2023.
Q: What specific health challenges is Théo Grataloup facing?
A: Théo has faced severe health challenges. specifically, Théo was born with severe malformations affecting his esophagus, larynx, and respiratory system and has endured:
- Over 50 surgeries under general anesthesia.
- A tracheostomy (surgical opening in his neck) to aid breathing and speech.
- Difficulty eating requiring him to rely on a feeding tube until the age of 6.
Q: What has been the impact of Théo’s health condition on his family?
A: As stated by the family’s attorney, Alice Gourlay-Duplessis, Théo’s condition shaped the family’s life of constant care and surgical interventions.
This has substantially affected the entire family.
Q: What is the meaning of the “Monsanto Papers”?
A: The “Monsanto Papers” are internal documents that allegedly reveal how Monsanto, prior to its acquisition by Bayer, orchestrated a disinformation campaign. The aim was to ensure that the continued marketing of Roundup glyphosate and other similar products continued, despite what they state about the toxicity of the herbacide.
Q: What is the legal status of glyphosate in the European union?
A: In 2023, the European Union reauthorized the use of glyphosate for a ten-year period, which is a key element of Bayer’s defense, arguing that glyphosate is not considered a significant concern for public health and it’s safe to be used as a herbicide.
Q: Is this the first time Monsanto/Bayer has faced legal action over the effects of glyphosate?
A: No, this is not the first case. In France, Monsanto was previously convicted in 2012 for the poisoning of a farmer named Paul François by Lasso, another herbicide produced by the company. This suggests ongoing legal exposure for the company related to its herbicide products.
Q: what are the next steps in the Grataloup case?
A: A decision in the Grataloup case is expected on July 31,offering a crucial verdict in this legal battle. the anticipation is palpable in the legal community.
Q: How does this case mirror david and Goliath’s famous battle?
A: The Grataloup’s family feel like they are the David,and the company like Goliath because of the financial resources,the resources being legal,and the access to public relations. The mother’s words speak of the battle – “This hearing highlighted how much we are David against Goliath”. The family has been facing significant difficulties on top of the health condition.
Table: Summary of key arguments
| Argument | Grataloup Family | Bayer |
|---|---|---|
| Causal Link | Strong evidence of a causal link between glyphosate exposure and Théo’s birth defects. | Denies any causal link based on scientific evidence and regulatory approvals. The company is saying it’s up to the European Union that glyphosate is considered as safe for humans. |
| Liability | Seeks to hold Bayer accountable for the alleged harm caused by glyphosate. | Claims that bayer France was not the producer or distributor of the herbicide. |
| Evidence | Presents a “very telling chronology,” medical expert testimony, and scientific studies. | Questions credibility of witnesses and authenticity of evidence with a focus on legal technicalities. |
This case highlights the complex legal and ethical issues surrounding glyphosate use, its potential health impacts, and the responsibility of agricultural companies.
Disclaimer: This article is for informational purposes onyl and does not constitute legal advice.